NL-OMON19867招募中不适用
Predicting venous thromboembolism with the FGT test in patients with pancreatic cancer
Amsterdam UMC0 个研究点目标入组 112 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Adenocarcinoma of the pancreas confirmed by histology or radiologic imaging.
- •Planned for a new course of chemotherapy
- •18 years of age or older
- •Fully capable of making health related decisions and written informed consent.
排除标准
- •Adjuvant chemotherapy.
- •Current prophylactic or therapeutic anticoagulant therapy (unfractionated heparin, low molecular weight heparin, vitamin K antagonists, or direct oral anticoagulants).
- •Venous thromboembolism < 3 months prior to chemotherapy.
- •Surgery within the last month
- •Start of chemotherapy before enrolment
- •The presence of an inferior vena cava filter
- •Currently pregnant
- •Life expectancy of <3 months
- •Bacterial or viral infection in the previous 2 weeks, defined by fever and clinical symptoms.
- •Chemotherapy in the last month
研究者
相似试验
招募中
不适用
Predicting venous thromboembolism in patients with pancreatic cancer.venous thromboembolismblood clot10014523NL-OMON52393Academisch Medisch Centrum300
招募中
不适用
Risk assessment of venous thromboembolism in patient with inflammatory bowel diseaseInflammatory bowel diseaseJPRN-UMIN000023262Chiba University Hospital180
已完成
不适用
Assessment of venous thromboembolic disease (VTE) in oncology and haematology patients who presented to the Launceston General Hospital for treatment of their malignant disordervenous thromboembolic diseaseMalignant disorderBlood - Haematological diseasesCancer - Any cancerACTRN12611000762954Clifford Craig Medical Trust Fund766
已完成
不适用
Assessment of venous thromboembolic disease (VTE) in medical patients who presented to the Launceston General Hopspital (LGH)Venous thromboembolism (VTE) among medical patients.Blood - Clotting disordersACTRN12611001255976Clifford Craig Medical Trust Fund1,200
招募中
不适用
Prospective study of venous thromboembolism and bleeding complications associated with primary and secondary VTE prevention during pregnancy and postpartum in women with previous VTE, hereditary thrombophilia or antiphospholipid syndromeO22.3D68.5Deep phlebothrombosis in pregnancyPrimary thrombophiliaDRKS00028688niversitätsklinikum RegensburgUniversitäres Gefäßzentrum - Bereich Angiologie1,000